Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Westrock Coffee Company Q2 2026 Earnings Call - Free Cash Flow Turns Positive Ahead of Schedule as Capital Intensity Collapses
Westrock Coffee Company just crossed the finish line it spent years sprinting toward. The Q2 2026 print flips the script on a capital-intensive buildout that weighed on margins for years. Free cash fl...
- Consolidated adjusted EBITDA hit a record $21.3 million in Q2, up nearly 39% year-over-year.
- Free cash flow flipped positive in Q2, arriving a quarter ahead of the company’s original timeline.
- Consolidated net sales reached approximately $306 million, an 8.8% increase, with first-half sales up 24% to $614 million.
- +9 more takeaways
Senseonics Q2 2026 Earnings Call - Revenue and Margins Surge as In-House Commercialization Pays Off, Prompting Raised Full-Year Guidance
Senseonics delivered a quarter that validates its core strategic pivot. Full commercialization back in-house, combined with aggressive DTC marketing and the Eon Care insertion network, drove U.S. reve...
- Q2 net revenue reached $14.5 million, a 120 percent year-over-year increase driven by Eversense 365 adoption and the elimination of the Ascensia revenue share.
- U.S. revenue surged more than 150 percent to $12.6 million, with active prescribers growing 130 percent year over year.
- Gross margin expanded to 59 percent, beating prior guidance and marking the company’s strongest organic performance in history.
- +7 more takeaways
INmune Bio Q2 2026 Earnings Call - MHRA Alignment Clears Path for Late 2026 Ebstrocel Filing
INmune Bio is converging on a pivotal regulatory inflection point. Management confirmed formal MHRA alignment across clinical, non-clinical, and manufacturing packages for Ebstrocel, pushing the UK ma...
- MHRA alignment secured across CMC, non-clinical, and clinical packages, removing regulatory guesswork for the UK Ebstrocel filing.
- UK marketing authorization application targets late Q3 or early Q4 2026, with conditional approval sought for recessive dystrophic epidermolysis bullosa.
- Sequential global filings planned, including a European Medicines Agency submission in early 2027 and a US Biologics License Application in Q1 2027.
- +9 more takeaways
Natural Grocers Q3 FY2026 Earnings Call - Management Trims Full-Year Guidance as Basket Growth Offsets Transaction Declines
Natural Grocers delivered another quarter of measured resilience in a market that refuses to hand out free passes. Comparable store sales accelerated to 1.2%, but the math tells a clearer story. Shopp...
- Daily average comparable store sales accelerated to 1.2% from 0.5%, driven by a 3.1% increase in basket size that offset a 1.8% decline in transaction count.
- Npower Rewards program penetration rose two percentage points year-over-year to 84%, with members consistently outperforming non-members across sales, traffic, and basket size.
- Management lowered full-year fiscal 2026 comp sales guidance to 1.5-2.0% and diluted EPS guidance to $2.07-$2.11, reflecting a more cautious consumer environment.
- +7 more takeaways
Westwood Holdings Group Q2 2026 Earnings Call - Legacy Value Outflows Offset by Rapid ETF and Private Capital Scaling
Westwood Holdings Group reported steady second-quarter revenue of $25.3 million and economic earnings of $3.0 million, but the headline story is a structural pivot. The firm shed $1.6 billion in asset...
- Q2 revenue held at $25.3 million, up from $23.1 million a year ago, as ETF and private capital growth neutralized legacy AUM erosion.
- Net outflows reached $1.6 billion, concentrated in institutional large-cap value and small-cap strategies as clients rotate toward passive ETFs and consolidated mandates.
- The ETF platform crossed $400 million in July, with the Enhanced Income Series and YLDW fund gaining platform approvals despite recent net outflows.
- +8 more takeaways
SandRidge Energy Second Quarter 2026 Earnings Call - Zero-Debt Balance Sheet and Cherokee Expansion Fuel 49% EBITDA Growth
SandRidge Energy delivered another quarter of disciplined execution, turning higher oil averages near $95 per barrel into a 49 percent jump in adjusted EBITDA to $34 million. Management continues to t...
- Production and revenue surged, with output rising 11% year-over-year to 19.7 MBOE per day and revenue jumping 48% to roughly $51 million.
- Adjusted EBITDA expanded 49% to $34 million, driven by higher oil averages near $95 per barrel and strict cost controls.
- The balance sheet remains pristine with $115 million in cash, zero debt, and a negative net leverage position that insulates the company from market volatility.
- +7 more takeaways
Natuzzi S.p.A. Q1 2026 Earnings Call - Italian Plant Closures and Romania Production Shift Target Margin Recovery
Q1 2026 delivered a blunt wake-up call for Natuzzi. External headwinds like US tariffs, a frozen housing market, and geopolitical friction collided with an oversized Italian manufacturing base. Manage...
- Q1 2026 results were officially labeled disappointing, driven by US tariffs, historically low housing activity, weak consumer sentiment, and margin compression from relocating Natuzzi Editions production to Italy.
- Management is consolidating its Italian manufacturing footprint from five operating plants down to two to eliminate fixed costs that no longer match sales volume.
- Natuzzi Editions production for the US market will shift from Italy to Romania, a move designed to capture a 25 percent EBIT margin on roughly €30 million to €40 million in annual volume.
- +7 more takeaways
"Sunstone Hotel Investors" Q2 2026 Earnings Call - Raised 2026 Guidance and Recycles Sale Proceeds into Accretive Share Buybacks
Sunstone Hotel Investors delivered a second quarter that outpaced expectations, with adjusted FFO per share climbing 14% and portfolio RevPAR expanding 9.3%. The catalyst was a broader recovery in lei...
- Second-quarter adjusted FFO per diluted share climbed 14% year-over-year to $0.32, driven by stronger-than-expected leisure demand and disciplined cost controls.
- Portfolio-wide RevPAR expanded 9.3%, with resorts leading at nearly 27% growth, while urban and convention hotels posted solid mid-single-digit gains.
- Management raised full-year 2026 guidance, now projecting RevPAR growth of 7% to 9% and adjusted EBITDAre between $245 million and $255 million.
- +7 more takeaways
"Matador Resources" Q2 2026 Earnings Call - Debt Falls Below $1 Billion as Production Guidance Rises to 7% Oil Growth
Matador Resources is running hot in the second quarter of 2026, generating $303 million in adjusted free cash flow while successfully pushing total bank debt under the $1 billion mark. The company dep...
- Q2 adjusted free cash flow reached $303 million, with full-year guidance raised to approximately $900 million.
- Management deployed $200 million of quarterly cash flow to retire bank debt, pushing total borrowings below $1 billion.
- Oil production growth guidance was lifted from 4% to 7% year-over-year, achieved while reducing capital expenditures by 1%.
- +9 more takeaways
"Loar Holdings" Q2 2026 Earnings Call - 16th Sequential EBITDA Growth Streak and 40.5% Margin Expansion Fuel Raised Full-Year Outlook
Loar Holdings delivered another quarter of disciplined execution, pushing record sales to $172 million and expanding adjusted EBITDA margins to 40.5 percent. The sixteenth consecutive quarter of seque...
- Record revenue and margin expansion: Q2 sales hit $172 million, up 17% year-over-year, while adjusted EBITDA margins expanded 220 basis points to 40.5%.
- Sixteen-quarter growth streak: Adjusted EBITDA has risen sequentially for 16 straight quarters, underscoring disciplined execution across all business units.
- Commercial OEM acceleration: OEM sales surged 28% as production bottlenecks at Boeing and Airbus eased, with the 787, A320, and 737 families driving the bulk of the upside.
- +7 more takeaways